Tuberculosis Research and Epidemiology

149 ta ish

1. Multidrug-resistant tuberculosis in Uzbekistan: results of a nationwide survey, 2010 to 2011

   Dilrabo Ulmasova, G Uzakova, M N Tillyashayhov +17

   MaqolaTuberculosis Research and EpidemiologyEurosurveillance201315 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.163910

2. Multidrug-resistant Tuberculosis in Central Asia

   Helen Cox, Juan Daniel Orozco, Roy Male +6

   MaqolaTuberculosis Research and EpidemiologyEmerging infectious diseases20046 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.020023

3. A 24-Week, All-Oral Regimen for Rifampin-Resistant Tuberculosis

   Bern-Thomas Nyang’wa, Catherine Berry, Emil Kazounis +15

   MaqolaTuberculosis Research and EpidemiologyNew England Journal of Medicine20225 iqtibos

   ABIABI:AkademIndex/openalex/2022.article.000002

4. Factors Associated with Unfavorable Treatment Outcomes in New and Previously Treated TB Patients in Uzbekistan: A Five Year Countrywide Study

   Jamshid Gadoev, Damin Asadov, Mirzagolib Tillashaykhov +14

   MaqolaTuberculosis Research and EpidemiologyPLoS ONE20154 iqtibos

   ABIABI:AkademIndex/openalex/2015.article.000023

5. Where there is hope: a qualitative study examining patients’ adherence to multi-drug resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Jane Greig +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20164 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000054

6. Effectiveness and safety of standardised shorter regimens for multidrug-resistant tuberculosis: individual patient data and aggregate data meta-analyses

   Faiz Ahmad Khan, M Salim, Philipp du Cros +9

   Sharh maqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20174 iqtibos

   ABIABI:AkademIndex/openalex/2017.review-article.000004

7. Modelling the effect of short-course multidrug-resistant tuberculosis treatment in Karakalpakstan, Uzbekistan

   James M. Trauer, Jay Achar, Nargiza Parpieva +7

   MaqolaTuberculosis Research and EpidemiologyBMC Medicine20163 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.195695

8. Person-centred care in practice: perspectives from a short course regimen for multi-drug resistant tuberculosis in Karakalpakstan, Uzbekistan

   Shona Horter, Beverley Stringer, Nell Gray +5

   MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20203 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.195708

9. Acquired bedaquiline resistance in Karakalpakstan, Uzbekistan

   Parvati Nair, T. Hasan, K. K. Zaw +9

   MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20223 iqtibos

   ABIABI:AkademIndex/openalex/2026.other.281624

10. ‘They prefer hidden treatment': anti-tuberculosis drug-taking practices and drug regulation in Karakalpakstan

    Beverley Stringer, Karen Lowton, Mirzagaleb N. Tillashaikhov +5

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20162 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000087

11. Health system support and health system strengthening: two key facilitators to the implementation of ambulatory tuberculosis treatment in Uzbekistan

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    MaqolaTuberculosis Research and EpidemiologyHealth Economics Review20162 iqtibos

    ABIABI:AkademIndex/openalex/2016.article.000128

12. Trends, Characteristics and Treatment Outcomes of Patients with Drug-Resistant Tuberculosis in Uzbekistan: 2013–2018

    Khasan Safaev, Nargiza Parpieva, Irina Liverko +5

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.000207

13. Antituberculosis Activity and Pharmacokinetics of Polymer Conjugates of Isoniazid and Ethambutol

    Ш. А. Шомуротов, Oliy Ravshanovich Akhmedov, А. С. Тураев +1

    MaqolaInfectious Diseases and TuberculosisPharmaceutical Chemistry Journal20212 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.001447

14. Scaling Up Molecular Diagnostic Tests for Drug-Resistant Tuberculosis in Uzbekistan from 2012–2019: Are We on the Right Track?

    Sharofiddin Yuldashev, Nargiza Parpieva, Salikhdjan Alimov +6

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20212 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.262609

15. Ambulatory tuberculosis treatment in post-Semashko health care systems needs supportive financing mechanisms

    Stefan Köhler, Damin Asadov, Andreas Bründer +4

    MaqolaHIV/AIDS Impact and ResponsesThe International Journal of Tuberculosis and Lung Disease20142 iqtibos

    ABIABI:AkademIndex/openalex/2026.other.364601

16. The Beijing genotype and drug resistant tuberculosis in the Aral Sea region of Central Asia

    Helen Cox, Tanja Kubica, Daribay Doshetov +3

    MaqolaTuberculosis Research and EpidemiologyRespiratory Research20051 iqtibos

    ABIABI:AkademIndex/openalex/2005.article.000006

17. Tuberculosis Recurrence and Mortality after Successful Treatment: Impact of Drug Resistance

    Helen Cox, Yared Kebede, Sholpan Allamuratova +8

    MaqolaTuberculosis Research and EpidemiologyPLoS Medicine20061 iqtibos

    ABIABI:AkademIndex/openalex/2006.article.000008

18. Delay in the diagnosis and treatment of pulmonary tuberculosis in Uzbekistan: a cross-sectional study

    Tatiana Belkina, Doniyor S Khojiev, Mirzagaleb Tillyashaykhov +4

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20141 iqtibos

    ABIABI:AkademIndex/openalex/2014.article.000040

19. Revised Definitions of Multidrug-Resistant Tuberculosis Treatment Outcomes: Closer to the Reality?

    Mathieu Bastard, Maryline Bonnet, Philipp du Cros +9

    BoshqaTuberculosis Research and EpidemiologyAmerican Journal of Respiratory and Critical Care Medicine20151 iqtibos

    ABIABI:AkademIndex/openalex/2015.other.000002

20. Impact of pyrazinamide resistance on multidrug-resistant tuberculosis in Karakalpakstan, Uzbekistan

    Johanna Kuhlin, Chris Smith, Atadjan Khaemraev +8

    MaqolaTuberculosis Research and EpidemiologyThe International Journal of Tuberculosis and Lung Disease20181 iqtibos

    ABIABI:AkademIndex/openalex/2018.article.000181

21. Standardised shorter regimens <i>versus</i> individualised longer regimens for rifampin- or multidrug-resistant tuberculosis

    S.K. Abidi, Jay Achar, M.M. Assao Neino +34

    MaqolaTuberculosis Research and EpidemiologyEuropean Respiratory Journal20191 iqtibos

    ABIABI:AkademIndex/openalex/2019.article.000020

22. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

    A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

    MaqolaTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 iqtibos

    ABIABI:AkademIndex/openalex/2019.article.000129

23. The study of life quality parameters in children and adolescents with HIV associated tuberculosis

    Adzhablaeva-Dinara Namazovna

    MaqolaTuberculosis Research and EpidemiologyTuberculosis and lung diseases20201 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.000868

24. Prevention Of Anemia In Patients With Tuberculosis

    Mamatkulova Feruza Xaydarovna, Mamatova Nargiza Toirjonovna, Ruziboeva Oyjamol Narzullaevna

    MaqolaTuberculosis Research and EpidemiologyThe American Journal of Medical Sciences and Pharmaceutical Research20201 iqtibos

    ABIABI:AkademIndex/openalex/2020.article.000973

25. Factors Associated with Unfavourable Treatment Outcomes in Patients with Tuberculosis: A 16-Year Cohort Study (2005–2020), Republic of Karakalpakstan, Uzbekistan

    Jamshid Gadoev, Damin Asadov, Anthony Harries +11

    MaqolaTuberculosis Research and EpidemiologyInternational Journal of Environmental Research and Public Health20211 iqtibos

    ABIABI:AkademIndex/openalex/2021.article.000489